In This Article:
Japan's stock markets have recently experienced sharp weekly losses, with the Nikkei 225 Index falling by 6.0% and the broader TOPIX Index down by 5.6%. Amid this market volatility, identifying growth companies with high insider ownership can offer unique opportunities for investors seeking stability and potential upside. In this article, we will explore three top Japanese growth stocks characterized by significant insider ownership, a factor that often indicates strong confidence from those closest to the company's operations.
Top 10 Growth Companies With High Insider Ownership In Japan
Name | Insider Ownership | Earnings Growth |
Hottolink (TSE:3680) | 27% | 59.7% |
Micronics Japan (TSE:6871) | 15.3% | 39.8% |
Kasumigaseki CapitalLtd (TSE:3498) | 34.8% | 43.3% |
Medley (TSE:4480) | 34% | 28.7% |
Kanamic NetworkLTD (TSE:3939) | 25% | 28.9% |
SHIFT (TSE:3697) | 35.4% | 32.8% |
Money Forward (TSE:3994) | 21.4% | 66.8% |
ExaWizards (TSE:4259) | 21.9% | 91.1% |
Astroscale Holdings (TSE:186A) | 20.9% | 90% |
Soracom (TSE:147A) | 16.5% | 54.1% |
Below we spotlight a couple of our favorites from our exclusive screener.
DIP
Simply Wall St Growth Rating: ★★★★☆☆
Overview: DIP Corporation, a labor force solution company, provides personnel recruiting services in Japan and has a market cap of ¥163.09 billion.
Operations: The company's revenue segments include personnel recruiting services in Japan.
Insider Ownership: 39.1%
Return On Equity Forecast: 24% (2027 estimate)
DIP Corporation has shown substantial growth with earnings increasing by 20% over the past year and is forecasted to continue growing its revenue at 11.4% annually, outpacing the Japanese market's average. The company recently announced a share repurchase program worth ¥5 billion to enhance shareholder value, indicating strong confidence from insiders. Additionally, DIP's return on equity is projected to be high at 24.4% in three years, further underscoring its growth potential.
-
Unlock comprehensive insights into our analysis of DIP stock in this growth report.
-
Our expertly prepared valuation report DIP implies its share price may be lower than expected.
PeptiDream
Simply Wall St Growth Rating: ★★★★★☆
Overview: PeptiDream Inc. is a biopharmaceutical company focused on the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics, with a market cap of ¥361.22 billion.
Operations: PeptiDream Inc. generates revenue from the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.